Biocon Limited — Updates, 05-08-2026: Press Release
05-08-2026 | 05:02 pm
05-08-2026 | 05:02 pm
Biocon's consolidated income rose 9% to Rs 4,391 Cr, with net profit surging 355% to Rs 141 Cr. Biopharma revenue jumped 17% on new US/EU biosimilar/generic launches and EMA approval for its Malaysia plant, offsetting challenges in Services.
No comments yet. Be the first to comment!
